May 06, 2025 / 12:00PM GMT
Operator
It's Q1 2025 report presentation. (Operator Instructions) Now I will hand the conference over to the speaker's CEO, Erik Manting; and CFO, Lotta Ferm. Please go ahead.
Erik Manting - Mendus AB(publ)-Chief Executive Officer
Thank you. First of all, everybody, thanks for joining on what is a sunny day here in Stockholm for the Mendus Q1 financial report and business updates. In Q1, we reported the feedback we got from the regulatory agencies on our preparations for a registration trial with our lead products vididencel in AML, and that feedback was supportive of our efforts both in terms of the trial design, and other trial related preparations, but also with respect to our next steps that will move the production of the product towards large scale GMP production.
It's important we stay close to the regulators and ask them for feedback regularly to make sure that we are moving in the right direction, and that was something we confirmed in a press release earlier this year.
We also are preparing a deeper pipeline
Q1 2025 Mendus AB (publ) Earnings Call Transcript
May 06, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers